Skandinaviska Enskilda Banken (SEB)
JANX icon

Skandinaviska Enskilda Banken (SEB)’s Janux Therapeutics JANX Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-177,820
Closed -$4.11M – 844
2025
Q2 		$4.11M Hold
177,820
– – 0.02% 457
2025
Q1 		$4.8M Sell
177,820
-27,347
-13% -$1.03M 0.02% 425
2024
Q4 		$10.8M Buy
205,167
+170,520
+492% +$9.02M 0.05% 269
2024
Q3 		$1.57M Buy
34,647
+11,030
+47% +$480K 0.01% 624
2024
Q2 		$989K Hold
23,617
– – ﹤0.01% 643
2024
Q1 		$889K Buy
+23,617
New +$514K ﹤0.01% 668

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s JANX Position: Q3 2025 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Janux Therapeutics (JANX) in Q3 2025, closing a stake of 177,820 shares — an estimated $4.11M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in JANX in Q1 2024 and held it in 6 quarters. The position peaked at $10.8M in Q4 2024. 174 funds tracked by Wall St. Rank hold JANX as of Q3 2025.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Janux Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 177,820 Janux Therapeutics shares in Q3 2025, an estimated $4.11M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Janux Therapeutics in Q1 2024 and held it in 6 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Janux Therapeutics position peaked at $10.8M in Q4 2024.
  • 174 funds tracked by Wall St. Rank held Janux Therapeutics as of Q3 2025.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2025, filed 7 Nov 2025.